Pb2+ via protein kinase C inhibits nicotinic cholinergic modulation of synaptic transmission in the hippocampus

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 2, 2004, Pages 700-710

  Braga, Maria F M ^a,c   Pereira, Edna F R ^a   Mike, Arpad ^a,d   Albuquerque, Edson X ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BISINDOLYLMALEIMIDE; CARBAZOLE DERIVATIVE; CHOLINERGIC RECEPTOR; GO 7874; INDOLE DERIVATIVE; LEAD; NICOTINIC RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RO 318425; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; GLUTAMIC ACID;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FETUS; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPSE; SYNAPTIC TRANSMISSION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; CHOLINERGIC AGENTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; LEAD; NEURONS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION;

EID: 6344242979     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.070466     Document Type: Article

References (40)

1. Alkondon M, Pereira EFR, Eisenberg HM, and Albuquerque EX (1999) Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 19:2693-2705.
2. Atchison WD (2003) Effects of toxic environmental contaminants on voltage-gated calcium channel function: from past to present. J Bioenerg Biomembr 35:507-532.
3. Bellinger D, Leviton A, Waternaux C, Needleman H, and Rabinowitz M (1987) Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316:1038-1043.
4. Bielarczyk H, Tian X, and Suszkiw JB (1996) Cholinergic denervation-like changes in rat hippocampus following developmental lead exposure. Brain Res 708:108-115.
5. Braga MFM, Pereira EFR, and Albuquerque EX (1999a) Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Res 826:22-34.
6. Braga MFM, Pereira EFR, Marchioro M, and Albuquerque EX (1999b) Lead increases tetrodotoxin-insensitive spontaneous release of glutamate and GABA from hippocampal neurons. Brain Res 826:10-21.
7. Dempster J (1989) Microcomputers in physiology: a practical approach, in The Computer Analysis of Electrophysiological Data (Frazer PJ ed) pp 51-93, Oxford Press, Oxford.
8. Downing JE and Role LW (1987) Activators of protein kinase C enhance acetylcholine receptor desensitization in sympathetic ganglion neurons. Proc Natl Acad Sci USA 84:7739-7743.
9. Fenster CP, Beckman ML, Parker JC, Sheffield EB, Whitworth TL, Quick MW, and Lester RA (1999) Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C. Mol Pharmacol 55:432-443.
10. 3H]MK-801 binding to the NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett 148:27-30.
11. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv 391:85-100.
12. Ishihara K, Alkondon M, Montes JG, and Albuquerque EX (1995) Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast desensitizing nicotinic currents by lead. J Pharmacol Exp Ther 273:1471-1482.
13. Kleinschroth J, Hartenstein J, Rudolph C, and Schächtele C (1995) Novel indolocarbazole protein kinase C inhibitors with improved biochemical and physicochemical properties. Bioorg Med Chem Lett 5:55-60.
14. Lanphear BP, Dietrich K, Auinger P, and Cox C (2000) Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep 115:521-529.
15. Lasley SM and Gilbert ME (2000) Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology 21: 1057-1068.
16. Lidsky TI and Schneider JS (2003) Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126:5-19.
17. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51:397-401.
18. Majewski H and Iannazzo L (1998) Protein kinase C: a physiological mediator of enhanced transmitter output. Prog Neurobiol 55:463-475.
19. Marchioro M, Swanson KL, Aracava Y, and Albuquerque EX (1996) Glycine- and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. J Pharmacol Exp Ther 279:143-153.
20. Markovac J and Goldstein GW (1988) Picomolar concentrations of lead stimulate brain protein kinase C. Nature (Lond) 334:71-73.
21. Mike A, Castro NG, and Albuquerque EX (2000a) Choline and acetylcholine have similar kinetic properties of activation and desensitization on the α7 nicotinic receptors in rat hippocampal neurons. Brain Res 882:155-168.
22. 2+ of α7-containing nicotinic acetylcholine receptors in hippocampal neurons. Brain Res 873:112-123.
23. Moody WJ (1998) Control of spontaneous activity during development. J Neurobiol 37:97-109.
24. Moss SJ, McDonald BJ, Rudhard Y, and Schoepfer R (1996) Phosphorylation of the predicted major intracellular domains of the rat and the chick neuronal nicotinic acetylcholine receptor α7 subunit by cAMP-dependent protein kinase. Neuropharmocology 35:1023-1028.
25. Needleman H (2004) Lead poisoning. Anna Rev Med 55:209-222.
26. Nightingale SL (1991) From the Food and Drug Administration. J Am Med Assoc 265:1802.
27. 2+-induced deficits of LTP and spatial learning. Neuroscience 99:233-242.
28. Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, and Albuquerque EX (2002) Unconventional ligands and modulators of nicotinic receptors. J Neurobiol 53:479-500.
29. Radcliffe KA, Fisher JL, Gray R, and Dani JA (1999) Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann NY Acad Sci 888:591-610.
30. Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ Jr, and Rhoads GG (2001) The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med 344:1421-1426.
31. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, and Patrick JW (1993) Molecular cloning, functional properties and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
32. 2+ inhibition of sympathetic alpha 7-nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilation in porcine basilar arteries. J Pharmacol Exp Ther 305:1124-1131.
33. Stokes L, Letz R, Gerr F, Kolczak M, McNeill FE, Chettle DR, and Kaye WE (1998) Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med 55:507-516.
34. Suszkiw JB (2004) Presynaptic disruption of transmitter release by lead. Neurotoxicology 25:599-604.
35. Swanson KL, Marchioro M, Ishihara K, Alkondon M, Pereira EFR, and Albuquerque EX (1997) Neuronal targets of lead in the hippocampus: relationship to low-level lead intoxication. Comprehensive Toxicol 11:470-491.
36. Tanaka C and Nishizuka Y (1994) The protein kinase C family for neuronal signaling. Annu Rev Neurosci 17:551-567.
37. Ujihara H and Albuquerque EX (1992) Developmental change of the inhibition by lead of NMDA-activated currents in cultured hippocampal neurons. J Pharmacol Exp Ther 283:868-875.
38. Vizi ES and Kiss JP (1998) Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus 8:566-607.
39. Wilkinson SE, Parker PJ, and Nixon JS (1993) Isoenzyme specificity of bisindolyl-maleimides, selective inhibitors of protein kinase C. Biochem J 294:335-337.
40. 2+. Eur J Pharmacol 291:399-406.